Current Projects

The Institutes’ research programmes aim to understand the disease process and develop novel and affordable therapies in order to intervene to prevent long term disablement and early death.

To this end, all our research projects have the potential to save many thousands of patient lives and are concerned with the fundamental mechanisms involved in blood coagulation, inflammation and atherogenesis, as well as how these processes are regulated.

Our multi-disciplinary approach allows us to address these investigations at a molecular level and with major bases in Bangalore, India as well as London, United Kingdom, we are currently accelerating our research projects.


The GARFIELD-AF Registry is a worldwide observational study of stroke prevention in patients with atrial fibrillation.


About TRI

Providing excellence in research, education and patient care.

Our Strategy

At both Thrombosis Research Institutes, we are committed to saving millions of lives, preventing long term disability and reducing healthcare costs by delivering pioneering advances in the detection, prevention and treatment of thrombosis.


Our Achievements

Our multidisciplinary programme of laboratory and clinical research has contributed to major advances in venous thromboembolism that have changed clinical practice.


Our Research

The Thrombosis Research Institute (TRI) has been at the centre of global understanding of thrombosis for 45 years, producing the highest calibre research into the condition.